Terumo announced that it plans to construct a new manufacturing facility for its Medical Care Solutions Company in Japan.
The company’s investment in the facility totals $382.9 million (¥52.2 billion). Terumo expects to complete construction in fiscal 2025. It’s located in the premises of the Kofu Factory in Yamanashi, Japan, according to a news release.
Once operations begin, the company plans to utilize the facility for its contract development and manufacturing organization (CDMO) business. It also plans to manufacture products related to peritoneal dialysis. Additionally, Terumo expects the facility to provide additional spaces to enable it to scale up production to meet future demand.
The Terumo CDMO business provides integrated support for drug-device combination products. This ranges from design to commercial manufacturing through partnerships with pharmaceutical companies. The company expanded its CDMO business globally over the past year or so, it said. It represents a pillar of its five-year growth strategy and Terumo said it wants to optimize production capacity.
Terumo also promotes peritoneal dialysis therapy by providing devices designed for easy use and the reduction of infection risk. Its dialysis solutions also reduce the burden on the patient’s body. The company aims to contribute to the improvement of the quality of peritoneal dialysis therapy. It also wants to meet the expected increase in product demand in this space.
